Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
- *Corresponding Author:
- Dr. Da-Yong Lu
School of Life Sciences, Shanghai University
Shanghai 200444, PR China
E-mail: [email protected]
Received date: September 18, 2012; Accepted date: September 18, 2012; Published date: September 25, 2012
Citation: Lu DY, Lu TR, Cao S (2012) Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers. Metabolomics 2:e121. doi:10.4172/2153-0769.1000e121
Copyright: © 2012 Lu DY, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
A major obstacle to control cancer growth and metastases in patients is the widespread inappropriate use of anticancer drugs. Individualized cancer chemotherapy (ICC) has been attracting increasing attentions in medical circle and will continue to show beneficial outcome in the future. This review addresses this issue by discussing one specific strategy of ICC, biomarker-oriented therapy. Many longstanding key debates and future trends are discussed.